Navigation Links
Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
Date:11/1/2007

HAYWARD, Calif., Nov. 1 /PRNewswire/ -- Arete Therapeutics Inc. today announced the initiation of a phase 1 clinical trial for its lead compound, AR9281, for the treatment of hypertension. AR9281 is a "first-in-class," orally-active inhibitor of soluble epoxide hydrolase (s-EH), a novel target for the treatment of hypertension. The trial will enroll up to 32 healthy adult volunteers and will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics for single ascending doses of AR9281.

"AR9281 inhibits s-EH, an enzyme that plays a key role in the cytochrome P450 pathway of arachidonic acid metabolism, and offers a unique mechanism of action as an antihypertensive agent," said Dinesh V. Patel, Ph.D., president and chief executive officer of Arete Therapeutics Inc. "We believe this first-in-class compound has great potential to be a unique 'antihypertensive-plus' drug that not only lowers blood pressure but also offers end organ protection of the heart and kidney, and protection against vascular inflammation."

"The preclinical safety and efficacy profile of AR9281 is very encouraging and provided a solid basis for the initiation of the clinical development phase of this new compound class," commented Randall Whitcomb, M.D., chief medical officer of Arete Therapeutics Inc. "We look forward to reporting results from the initial phase 1 clinical trial in 2008."

Arete Therapeutics' phase 1 single ascending dose, placebo-controlled clinical trial in healthy volunteers will obtain initial safety and tolerance information as well as detailed blood pressure measurements. Levels of s-EH specific biomarkers will be analyzed together with typical inflammatory markers as part of the pharmacodynamic assessment. Following successful completion of the single dose study, Arete plans to initiate a multiple dose phase 1 study, a food effect study, and studies in special populations.

About AR9281

AR9281 is a novel small molecule inhibi
'/>"/>

SOURCE Arete Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. VBI Provides Potential Targets to Diabetes Therapeutics
2. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
3. Bird Flu: Orissa Initiates Protective Measures
4. Biota Initiates Drug Testing War against Common Cold
5. Russia Initiates Mass Vaccination Of Poultry To Restrict Bird Flu
6. Government Initiates A Program To Curb HIV
7. Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2
8. Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial
9. Maxygen Initiates Phase IIa Clinical Trial of MAXY-G34 in Breast Cancer Patients
10. FDA approves Phase 0 trial which tests experimental drugs on humans
11. SARS-Free Taiwan to Mark End Phase of Global Fight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... Parker & Sons, Inc. a focused and dedicated ... contractor services announces reaching a milestone by providing 40 ... Arizona. Parker and Sons is comprised of a reliable ... customer service the number one priority. The company was ... one service vehicle and has since grown to become ...
(Date:12/19/2014)... Today, Balfleet.com , a leading dress company of ... promotion. All the old and new customers can get ... is well-known for its high quality trendy women’s dresses, ... and more. Its formal dresses are quality made and ... create an elegant look when paired with any accessory. ...
(Date:12/19/2014)... 2014 Sweetdressy.com , a leading ... its newest selection of cheap prom dresses for ladies ... in the world and clients can buy these dresses ... prom dresses feature cool cuts and delicate craftsmanship, and ... the middle-end market. Discount shipping costs are available for ...
(Date:12/19/2014)... December 19, 2014 Energy Textiles ... are now available. Celliant, the world’s leading responsive ... and pillowcases. , There are a number of ... circulation, increased oxygenation and balanced body temperature; which ... and pain relief; enhanced athletic performance; and overall ...
(Date:12/19/2014)... 19, 2014 Silver Dollar City ... record -- for the first time ever, Silver Dollar City ... Guinness World Records 2015, listing the park’s wood coaster Outlaw ... In additional awards announced this week, Silver Dollar City is ... in the US,” USA Today’s 10Best awards for “Best Public ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2
... take as many math courses as boys, influenced by close ... than boys, girls look to their close friends when they ... what math classes to take, confirming how significant peers are ... study conducted by researchers at the University of Texas at ...
... Permanente of Southern California Study ... ... to depression,treatment, already shown to improve health, can also cut total health-care,costs, ... issue of the American Journal of Managed Care., The results examine ...
... WASHINGTON, Feb. 6 The U.S. Agency for,International Development ... Female Genital Cutting (FGC). Zero Tolerance Day was,launched in ... of Nigeria,speaking on behalf of all the First Ladies ... absolutely no justification in today,s world for,this practice., ...
... Ark., Feb. 6 Aegis Therapies and ... of Health,Professions (RMUoHP) in Provo, Utah, announced ... have been selected to receive a scholarship ... therapy,doctorate program., Aegis is one of ...
... Annual Disaster Giving Program Provide,Financial Support, WASHINGTON, ... the South Tuesday night resulting in significant,damage to ... tornadoes left more than 45 people dead and ... tornadoes, providing,shelter, feeding victims and search and rescue ...
... - Population,Research Institute has joined other pro-life groups ... AIDS Relief (PEPFAR)., PEPFAR is up for ... Foreign Affairs Committee. According to PRI,s president Steven,Mosher, ... that put,the money directly in the hands of ...
Cached Medicine News:Health News:Friends' school achievement influences high school girls' interest in math 2Health News:Team Depression Treatment Cuts Total Senior Medical Costs 2Health News:Team Depression Treatment Cuts Total Senior Medical Costs 3Health News:From Kent Hill, USAID Assistant Administrator for Global Health on the Observance of International Day of Zero Tolerance 2Health News:Aegis Therapies and Rocky Mountain University of Health Professions Announce Scholarship Recipients 2Health News:Aegis Therapies and Rocky Mountain University of Health Professions Announce Scholarship Recipients 3Health News:American Red Cross Responds to Tornadoes in the Southeast 2
(Date:12/19/2014)... -- You,re visiting the dentist for what you think ... she says you need a root canal. Though it,s ... several questions and feel apprehensive about your upcoming procedure. ... to worry about. The Pennsylvania Dental Association (PDA) wants ... the public may have surrounding this common procedure that ...
(Date:12/19/2014)... , Dec. 19, 2014   Hospira, Inc. ... of injectable drugs and infusion technologies, today announced that ... Annual Healthcare Conference on Wednesday, Jan. 14, 2015, in ... scheduled to begin at 10:30 a.m. Pacific time on ... all interested parties through a live audiocast accessible via ...
(Date:12/19/2014)... 19, 2014  Monarch America Inc. (OTCQB: CANK) ("Monarch ... pleased to provide this review of the Company,s recent ... "Over this past year, we achieved many ... extremely proud to say that Monarch America is in ... has ever been," stated Eric Hagen , CEO ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3
... NEW YORK, Feb. 24, 2011 Get content ... Full year revenue was DKK ... driven by a positive development in all regions. ... increasing 17% and corresponding to an EBIT margin ...
... 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: ... development, manufacturing, and marketing of branded and proprietary pharmaceuticals ... unaudited financial results for the fourth quarter and fiscal ... 2011, before the market opens in the United States. ...
Cached Medicine Technology:Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2010 Unaudited Financial Results on Tuesday, March 8, 2011 2
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
Designed to be used for neuromuscular blockage monitoring. Provides for easy placement over the ulnar nerve on a patient's wrist. Dual element permits non-invasive monitoring using a single electrode...
... standby switch maintains power to the instrument without ... pulse/s) , Tetanus: 100 Hz (200 pulses/s) ... Current: Adjustable from 0-70 mA , Stimulus ... Indicators: Battery LED (green) indicates that the units ...
... peripheral nerve stimulator from B. Braun Medical. ... nerve stimulator functionality for over 10 years. ... available, a unique, under-the-glove hand held remote ... Dig. It allows the anesthesia provider operating ...
Medicine Products: